group and 64.7% (11/17) in the CS group. 18 patients had disease progression (NCS 10, CS 8); median TTP was 5.5 months in the NCS group and 3 months in the CS group, and average TTP was 5.3 months in NCS group and 3.1 months in CS group. The incidence of adverse events was similar for both groups. No adverse events of grade 3 skin rash or grade 3 infusion-related reactions were observed.
rectal carcinoma, evaluating the involvement of the mesorectal fat and mesorectal fascia is more important than T staging for planning treatment. We studied the accuracy of 3T MRI for prediction of mesorectal fascia involvement and circumferential resection margin (CRM; shortest distance between tumour and mesorectal fascia) in patients with rectal cancer.
Methods: 40 consecutive patients with biopsy-proven rectal cancer from the Department of Colorectal Surgery were included in the study. 3T MR imaging was done after patients had a 4-h fast and cleansing water enema. T1-weighted and T2-weighted images were obtained, with high resolution images in 3 planes.
The image series were evaluated after verification by an experienced gastrointestinal radiologist, and CRM measurements and mesorectal fascia involvement were documented. These results were compared with the final histopathology report.
Findings: Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 3T MRI for prediction of CRM involvement was 100%, 33.3%, 61.9%, and 100%, respectively.
Interpretation: 3T MRI has high sensitivity and NPV, and low specificity and PPV for prediction of CRM involvement. The low specificity could be due to the high resolution of the images, which picked up areas of tumour reaction, increased flow, and oedema. This low specificity is compounded by the difficulty in assessing CRM in cachectic patients and in low anterior tumours.
However, MR imaging has a high sensitivity and NPV for mesorectal fascia assessment, and is therefore indispensable for pre-operative staging of rectal cancer.
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Background: We used 3-deoxy-3- We share our experience of closure of such defects using a simple procedure, the thoraco-abdominal (TA) flap.
Methods: Between January, 2003, and December, 2010, a total of 1232 patients had surgery for breast tumours at our centre. Of these, 912 (74%) of patients had a mastectomy. 78 (8.5%) of patients had a large post-mastectomy defect that could not be closed primarily. Soft-tissue cover using the TA flap was done for all of these patients. The TA flap is a rotation-advancement variant of the fascio-cutaneous flap, with random pattern blood supply.
Findings: Primary healing could be achieved in 73 (94%) of patients who had TA flap cover. Three patients had marginal necrosis that responded to conservative treatment. Two patients developed major necrosis with loss of TA flap and needed salvage myocutaneous flap repair. All patients were able to receive the planned adjuvant chemo and/or radiation therapy.
Interpretation: The aim of surgery in large advanced breast tumours is adequate disease extirpation with early recovery, so that adjuvant therapy can be done to improve survival. The TA flap is a simple, safe, reliable, and effective technique with minimum morbidity for coverage of large post-mastectomy defects, and is particularly suited for surgeons and patients in our region.
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